|
FAM168B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62558855265615E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.800781745942E-13 |
| Normal-vs-Stage2 |
1.92271999999161E-05 |
| Normal-vs-Stage3 |
9.14046616173891E-13 |
| Normal-vs-Stage4 |
2.16082707282794E-12 |
| Stage1-vs-Stage2 |
2.117600E-01 |
| Stage1-vs-Stage3 |
3.407200E-01 |
| Stage1-vs-Stage4 |
2.637900E-02 |
| Stage2-vs-Stage3 |
7.799500E-02 |
| Stage2-vs-Stage4 |
1.424220E-02 |
| Stage3-vs-Stage4 |
2.443000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
1.396420E-04 |
| Normal-vs-Asian |
9.77930003642768E-09 |
| Caucasian-vs-AfricanAmerican |
2.579000E-01 |
| Caucasian-vs-Asian |
7.217200E-01 |
| AfricanAmerican-vs-Asian |
4.259400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15050199869893E-13 |
| Normal-vs-Female |
1.65045754840776E-12 |
| Male-vs-Female |
2.571600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.20279391686063E-12 |
| Normal-vs-Age(41-60Yrs) |
4.53526105559376E-13 |
| Normal-vs-Age(61-80Yrs) |
3.12305736827057E-12 |
| Normal-vs-Age(81-100Yrs) |
1.621000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.868000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.208600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.649000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.986200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.969600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.915800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.669900E-02 |
| Classical-VS-Follicular |
7.918200E-01 |
| Classical-VS-Other |
1.807430E-01 |
| Classical-VS-Normal |
1.68920433196718E-12 |
| Tall-VS-Follicular |
5.982000E-02 |
| Tall-VS-Other |
8.334400E-01 |
| Tall-VS-Normal |
4.74720263099471E-11 |
| Follicular-VS-Other |
3.224800E-01 |
| Follicular-VS-Normal |
1.49450000153095E-08 |
| Other-VS-Normal |
3.228700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.45132860863396E-13 |
| Normal-vs-N1 |
1.3559153799747E-12 |
| N0-vs-N1 |
1.385790E-02 |
|
|
